The CY2019 Proposed Rule for Medicare Advantage and Medicare Prescription Drug Benefit Programs
Webinar | 12.12.17, 8:00 AM EST - 9:30 AM EST
CMS issued the long-awaited proposed rule that would make major changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs. CMS proposes many changes that are intended to increase transparency and alleviate administrative burdens on MA organizations and Part D sponsors. Other changes implement the Comprehensive Addiction and Recovery Act and the 21st Century Cures Act. CMS also solicits comments on a number of important topics.
Please join us for a webinar during which members of our Health Care Group discuss some of the key provisions of the proposed rule.
Provisions that we will address include:
- Implementation of the Comprehensive Addiction and Recovery Act of 2016
- New Benefit Flexibility under Medicare Advantage
- Tiering and Other Part D Changes
- Changes to the Star Ratings Program and the Impact for Contract Consolidation
- Changes to the Part C and Part D Medical Loss Ratio Requirements
Contact
Participants

- Washington, D.C.
- D | +1.202.624.2683
Insights
Webinar | 11.17.26
Microplastics: Science, Regulation, and Legal Risk
Microplastics are plastic particles found across the environment—in water supplies, food sources, and human tissue—and have emerged as a frontline legal and regulatory issue. The science is developing quickly, and regulatory and litigation activity is following close behind, from EPA's inclusion of microplastics on its draft Sixth Contaminant Candidate List (CCL 6) as a priority contaminant group to growing state legislation and an expanding wave of private litigation. Companies across industries are facing increasing uncertainty and risk.
Webinar | 11.05.26

